MediPurpose Awarded Vizient Contract for SurgiLance™ Safety Lancets - MediPurpose
post-template-default,single,single-post,postid-21021,single-format-standard,bridge-core-2.5.9,qode-page-transition-enabled,ajax_fade,page_not_loaded,,qode-title-hidden,qode-theme-ver-24.4,qode-theme-bridge,disabled_footer_top,qode-wpml-enabled,wpb-js-composer js-comp-ver-7.7.1,vc_responsive

MediPurpose Awarded Vizient Contract for SurgiLance™ Safety Lancets

Atlanta, GA, June 21, 2021 – MediPurpose announced today that it has signed an agreement with Vizient to offer SurgiLance™ Safety Lancets to all Vizient members at contracted pricing.

Vizient is the largest member-driven healthcare performance improvement company in the US, providing solutions and services that improve the delivery of high-value care by aligning cost, quality and market performance for more than 50% of the nation’s acute care providers. Vizient provides expertise, analytics and advisory services, as well as a contract portfolio that represents more than $100 billion in annual purchasing volume, to improve patient outcomes and lower costs.


“MediPurpose has been serving Vizient members for many years and we look forward to continuing to serve them with quality products at affordable prices through this new contract,” said Patrick Yi, founder and CEO of MediPurpose.


Launched in 1999, SurgiLance™ Safety Lancets have remained a favorite among fingerstick users who love SurgiLance’s ease of use, comfort, safety and reliability. More than a billion SurgiLance™ Safety Lancets have been sold since 2000 with less than 1 complaint per 5 million units sold.


About MediPurpose

MediPurpose, founded in 1999, develops, manufactures, and distributes superior sharps safety products including the Anzen safety scalpel, SurgiLance safety lancets and MediPlus wound care products.

For more information about MediPurpose, please visit